SCPH(Delisted)
·NASDAQ
--
--(--)
Signals Analysis
Bullish signal 1
Bearish signal 1
Revenue Beats Expectation
EPS Below Expectations
Key Stats
0.0000DAY`S RANGE0.0000
0.000052 WK RANGE0.0000
0.0000
0.0000
--
--
--
--
--
--
--
--
--
--
--
--
--
--
0.0000
0.0000
0.0000
0.0000
About SCPH
Scpharmaceuticals Inc.
A pharmaceutical company focused on therapies based on transformative pharmaceutical prducts
25 Mall Road, Suite 203, Burlington, Massachusetts 01803
--
Scpharmaceuticals Inc., was incorporated as a limited liability company under the laws of the State of Delaware in February 2013. The company is a pharmaceutical company focused on developing and commercializing products with the potential to transform treatments, advance patient care and reduce medical costs. The Company's proprietary platform is designed to enable subcutaneous administration of treatments previously limited to intravenous or IV delivery. From the high cost that IV management usually requires, the company breaks this high cost requirement, which the company believes reduces the overall medical cost and improves the quality and convenience of care.
Company Financials
EPS
SCPH has released its 2025 Q2 earnings. EPS was reported at -0.34, versus the expected -0.3, missing expectations. The chart below visualizes how SCPH has performed over recent quarters, highlighting trends in earnings surprises.
Revenue & Expenses
SCPH has released its 2025 Q2 earnings report, with revenue of 16.04M, reflecting a YoY change of 99.17%, and net profit of -18.02M, showing a YoY change of -5.47%. The Sankey diagram below clearly presents SCPH's revenue sources and cost distribution.
Forecast
Wall Street Opinions
Price Target
Volume Profile
Trade Flow Insight
Seasonals
Community Forum
Loading...
Related News
No articles available
Related Symbols
You can ask Aime
No Data
